Metanalysis of 38 RCTs & 19 agents shows greater DEXA improvements assoc w/ greater reductions in vertebral & hip Fx risk. A 2% to 6% incr in total hip BMD--> expect 28%-66% reduced vert Fx risk. 2%-6% incr in hip BMD--> expect 16%-40% lower hip Fx risk https://t.co/ceY5X31xXh